Insider Shareholders with Direct Ownership of Vyne Therapeutics Inc. (VYNE)
This section provides a comprehensive overview of the insiders with direct ownership of Vyne Therapeutics Inc. (VYNE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
VYNE Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David Domzalski
PRESIDENT AND CEO |
1,302,344 | 132,182 | 496,696 $1.42 Million | 30 |
Sep 30, 2024
Reduced 0.14%
|
|
Mutya Harsch
CHIEF LEGAL OFFICER AND GC |
314,196 | 23,356 | 149,026 $424,724 | 25 |
Sep 30, 2024
Reduced 0.07%
|
|
Iain Stuart
CHIEF SCIENTIFIC OFFICER |
290,072 | 23,517 | 133,494 $380,457 | 22 |
Sep 30, 2024
Reduced 0.08%
|
|
Tyler Zeronda
CHIEF FINANCIAL OFFICER |
277,556 | 4,871 | 131,567 $374,965 | 20 |
Sep 30, 2024
Reduced 0.06%
|
|
Andrew Saik
Chief Financial Officer |
32,230 | 762 | 116,468 $331,933 | 3 |
May 28, 2021
Added 2.53%
|
|
Matthew T. Wiley
Chief Commercial Officer |
35,513 | 10,806 | 109,246 $311,351 | 6 |
Jun 30, 2021
Reduced 4.5%
|
|
Patrick G Lepore
Director |
133,000 | 0 | 36,472 $103,945 | 7 |
Nov 15, 2023
Added 26.28%
|